IFLR1000

Sistema / VTB Bank $240 million acquisition of a stake in OBL Pharm

28/12/2018
Private acquisition
Select tab

$ 240 million

Completed

28/12/2018

Overview:

  • Russian financial conglomerate Sistema and VTB Bank have agreed to acquire a stake in Pharmaceutical Enterprise Obolenskoe (OBL Pharm), a leading Russian pharmaceutical company, from Alvansa.

Prin Shasiharan - Researcher

Jurisdiction:

Russia

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:
Bryan Cave Leighton Paisner

Party: Alvansa (Seller)

Latham & Watkins

Party: Sistema (Acquirer)

Morgan Lewis & Bockius

Party: VTB Bank (Acquirer)

Related deals